Back
Sep 30
Scientific
SS 36 - GI 3: Liver - checking in on inhibitors, inSPECTing liver function, and making progress oligo-ly
MODERATOR(S)
Sangjune Lee, MD, MS, BS, FRCPC DABR - Tom Baker Cancer Centre
Higinia Cardenes, MD, PhD - Weill-Cornell Medical School
Credits
AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
12:45pm - 02:00pm PT
GI 3: Liver - checking in on inhibitors, inSPECTing liver function, and making progress oligo-ly
Speaker: Higinia Cardenes, MD, PhD - Weill-Cornell Medical School, NEW YORK -
12:45pm - 02:00pm PT
GI 3: Liver - checking in on inhibitors, inSPECTing liver function, and making progress oligo-ly
Speaker: Sangjune Lee, MD, MS, BS, FRCPC DABR - Tom Baker Cancer Centre, Calgary -
12:45pm - 12:55pm PT
Toripalimab Combined with Radiotherapy vs. Sorafenib in Advanced Hepatocellular Carcinoma with First Branch (Vp3) or Main Trunk (Vp4) Portal Vein Thrombosis: A Prospective, Open-Label, Randomized Tria
Speaker: Bo Chen, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing -
12:55pm - 01:05pm PT
Phase IB/II Study of Trifluridine/Tipiracil Hydrochloride (FTD/TPI) Plus Radiation Therapy for the Treatment of the Liver in Patients with Hepatic Metastases from Colorectal and Pancreatic Cancer
Speaker: Jennifer Wo, MD - Massachusetts General Hospital/ Harvard Medical School, Boston -
01:05pm - 01:15pm PT
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-Line Immunotherapy: A Phase II Clinical Study
Speaker: Shu Jung Hsu, MD, PhD - Zhongshan Hospital Fudan University, Shanghai -
01:15pm - 01:25pm PT
Efficacy and Safety of Camrelizumab and Apatinib in Combination with IMRT in Unresectable Hepatocellular Carcinoma: A Non-Randomised Phase 2 Study
Speaker: Hong-zhi Wang, MD, MS - Cancer Hospital, Chinese Academy of Medical Science, Peking Union Medical College, BeiJing -
01:25pm - 01:35pm PT
A Phase II Study of Durvalumab and Tremelimumab with Radiation Therapy in Patients with Advanced Hepatocellular Carcinoma and Biliary Tract Cancer
Speaker: Julie Koenig, MD - Mass General Brigham, Somerville -
01:35pm - 01:45pm PT
Sulfur Colloid SPECT/CT Tracking for Evaluation of Liver Function: Longitudinal Assessment During Radiation Therapy (STELLAR) Prospective Study - Towards Imaging Biomarker-guided Radiotherapy
Speaker: Smith Apisarnthanarax, MD - University of Washington Radiation Oncology, Seattle -
01:45pm - 01:55pm PT
Discussant
Speaker: Lauren Henke, MD, MS - University Hospitals/Case Western Reserve University, Cleveland